Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC13A5 | Q86YT5 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.45 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 3/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | CASP1 | P29466 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1738586 | 0.88 | ALDH1A1 (0.54) | SLC13A5ALDH1A1KMT2ATDP1MAPK1 | |
| SCHEMBL27567213 | 0.87 | ALDH1A1 (0.53) | SLC13A5ALDH1A1KMT2ATDP1MAPK1 | |
| SCHEMBL28002725 | 0.83 | ALDH1A1 (0.59) | ALDH1A1KMT2ATDP1MAPK1L3MBTL1 | |
| SCHEMBL27471654 | 0.81 | SLC13A5 (0.50) | SLC13A5ALDH1A1KMT2AMAPK1L3MBTL1 | |
| Citric Acid SCHEMBL15361754 | 0.80 | ALDH1A1 (0.54) | SLC13A5ALDH1A1KMT2ATDP1SLC6A2 | |
| Pyrimidine SCHEMBL29089078 | 0.80 | LMNA (0.47) | SLC13A5ALDH1A1KMT2ATDP1MAPK1 | |
| SCHEMBL29264743 | 0.79 | ALDH1A1 (0.56) | SLC13A5ALDH1A1KMT2ATDP1MAPK1 | |
| Phosphoric Acid SCHEMBL27799165 | 0.78 | ALDH1A1 (0.53) | ALDH1A1KMT2ATDP1MAPK1L3MBTL1 | |
| SCHEMBL28803598 | 0.78 | MEN1 (0.49) | SLC13A5ALDH1A1KMT2AMAPK1L3MBTL1 | |
| SCHEMBL6534838 | 0.78 | ALDH1A1 (0.65) | SLC13A5ALDH1A1KMT2ATDP1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4646205-A2 | COMBINATION THERAPIES FOR TREATMENT OF HEARING DISORDERS | Gateway Biotechnology, Inc. (US) | 2025-11-12 | — | — | EP | disclosed |
| WO-2024148287-A2 | COMBINATION THERAPIES FOR TREATMENT OF HEARING DISORDERS | GATEWAY BIOTECHNOLOGY, INC. (US) | 2024-07-11 | — | — | WO | disclosed |